News
NIH inventors are seeking a licensee and/or collaborator for a gene therapy to increase melanin production in patients with oculocutaneous albinism (OCA). OCA is characterized by decreased or absent pigmentation in the hair, skin, and eyes. This lack of pigmentation, caused by insufficient melanin
1 in every 200 people in the US with eye-related irritation are suffering from uveitis. Prolonged use of drugs that help treat chronic uveitis can cause serious side effects such as glaucoma. Having an alternative treatment for uveitis available is imperative. NIH inventors have proposed targeting
If you are an experienced Technology Transfer & Patent Specialist and you want to play a significant role in a dynamic organization, then consider joining the National Institutes of Health! This position is open 4/20-4/24/2026. Duties: Originate and draft complex Cooperative Research and Development
World Intellectual Property (IP) Day is April 26, 2026! This year’s theme is sports as IP is a prime driver of innovation, whether in sports or in business life. Join the Licensing Executives Society (LES) on April 24th to celebrate via a free webinar. In sports, cutting-edge equipment, team